应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00950 李氏大药厂
中秋节翌日休市 09-17 16:08:15
1.180
+0.010
+0.85%
最高
1.220
最低
1.160
成交量
4,500
今开
1.220
昨收
1.170
日振幅
5.13%
总市值
6.95亿
流通市值
6.95亿
总股本
5.89亿
成交额
5,430
换手率
0.00%
流通股本
5.89亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
李氏大药厂(00950)股价下跌5.085%,现价港币$1.12
阿斯达克财经 · 09-13
李氏大药厂(00950)股价下跌5.085%,现价港币$1.12
李氏大药厂(00950)将于10月3日派发中期股息每股0.02港元
智通财经网 · 08-28
李氏大药厂(00950)将于10月3日派发中期股息每股0.02港元
李氏大药厂(00950.HK):上半年实现纯利6247.8万港元 同比增加287.7%
格隆汇资讯 · 08-28
李氏大药厂(00950.HK):上半年实现纯利6247.8万港元 同比增加287.7%
李氏大药厂盘中异动 早盘急速下挫5.69%报1.160港元
市场透视 · 08-26
李氏大药厂盘中异动 早盘急速下挫5.69%报1.160港元
李氏大药厂(00950.HK)拟8月28日举行董事会会议审批中期业绩
格隆汇 · 08-16
李氏大药厂(00950.HK)拟8月28日举行董事会会议审批中期业绩
李氏大药厂盘中异动 早盘快速跳水7.26%
自选股智能写手 · 08-08
李氏大药厂盘中异动 早盘快速跳水7.26%
李氏大药厂盘中异动 下午盘快速拉升5.22%报1.210港元
自选股智能写手 · 08-06
李氏大药厂盘中异动 下午盘快速拉升5.22%报1.210港元
【港股异动 | 李氏大药厂(00950.HK)现涨超7% 预计上半年纯利最高达6300万港元】智通财经APP获悉,李氏大药厂(00950.
智通财经 · 08-05
【港股异动 | 李氏大药厂(00950.HK)现涨超7% 预计上半年纯利最高达6300万港元】智通财经APP获悉,李氏大药厂(00950.
港股异动 | 李氏大药厂(00950)现涨超7% 预计上半年纯利最高达6300万港元
智通财经 · 08-05
港股异动 | 李氏大药厂(00950)现涨超7% 预计上半年纯利最高达6300万港元
【盈喜股】李氏大药厂(00950)逆市涨8.33% 料中期股东应占纯利至多6300万港元
金吾财讯 · 08-05
【盈喜股】李氏大药厂(00950)逆市涨8.33% 料中期股东应占纯利至多6300万港元
李氏大药厂股价飙升11.01% 市值涨7850.33万港元
自选股智能写手 · 08-05
李氏大药厂股价飙升11.01% 市值涨7850.33万港元
港股异动丨发盈喜,李氏大药厂逆势高开近15%李氏大药厂(0950.HK)今早逆势高开14.81%报1.24港元,创6月14日以来新高
格隆汇 · 08-05
港股异动丨发盈喜,李氏大药厂逆势高开近15%李氏大药厂(0950.HK)今早逆势高开14.81%报1.24港元,创6月14日以来新高
【公司盈喜】李氏大药厂(00950)料中期股东应占纯利增长至最多6300万港元
金吾财讯 · 08-05
【公司盈喜】李氏大药厂(00950)料中期股东应占纯利增长至最多6300万港元
李氏大药厂发盈喜 预计中期股东应占纯利5800万至6300万港元
新浪港股 · 08-05
李氏大药厂发盈喜 预计中期股东应占纯利5800万至6300万港元
李氏大药厂发盈喜:料中期盈利升至5800万-6300万李氏大药厂(0950.HK)发盈喜,预期截至6月底止上半年将录得股东应占纯利介乎5800万至6300万港元,而2023年同期则录得约1600万港元
格隆汇 · 08-04
李氏大药厂发盈喜:料中期盈利升至5800万-6300万李氏大药厂(0950.HK)发盈喜,预期截至6月底止上半年将录得股东应占纯利介乎5800万至6300万港元,而2023年同期则录得约1600万港元
《盈喜》李氏大药厂(00950.HK)半年纯利倍翻 最少赚5,800万元
阿斯达克财经 · 08-04
《盈喜》李氏大药厂(00950.HK)半年纯利倍翻 最少赚5,800万元
【李氏大药厂(00950.HK)发盈喜,预计中期股东应占纯利5800万港元至6300万港元 同比增长】智通财经APP讯,李氏大药厂(00950.
智通财经 · 08-04
【李氏大药厂(00950.HK)发盈喜,预计中期股东应占纯利5800万港元至6300万港元 同比增长】智通财经APP讯,李氏大药厂(00950.
李氏大药厂(00950)发盈喜,预计中期股东应占纯利5800万港元至6300万港元 同比增长
智通财经 · 08-04
李氏大药厂(00950)发盈喜,预计中期股东应占纯利5800万港元至6300万港元 同比增长
李氏大药厂(00950.HK):香港首名患者已入组接受AU409治疗临床试验
阿斯达克财经 · 08-02
李氏大药厂(00950.HK):香港首名患者已入组接受AU409治疗临床试验
李氏大药厂:AU409临床研究预计25年中结束
和讯网 · 08-02
李氏大药厂:AU409临床研究预计25年中结束
暂无数据
公司概况
公司名称:
李氏大药厂
所属市场:
SEHK
上市日期:
--
主营业务:
李氏大药厂控股有限公司是一家主要从事药品开发、制造、市场推广及销售业务的香港投资控股公司。该公司通过两大分部运营。专利产品分部制造及销售自行研发的产品。其研发产品包括“尤靖安”、“立迈青”及“速乐涓”等。引进产品分部买卖引进的产品。其引进产品包括“菲普利”及“再宁平”等。该公司药品覆盖心血管及传染疾病、皮肤医学、肿瘤学、妇科学及眼科学等领域。该公司主要在中国及香港开展业务。
发行价格:
--
{"stockData":{"symbol":"00950","market":"HK","secType":"STK","nameCN":"李氏大药厂","latestPrice":1.18,"timestamp":1726560495011,"preClose":1.17,"halted":0,"volume":4500,"delay":0,"floatShares":588835343,"shares":588835343,"eps":0.028357,"marketStatus":"中秋节翌日休市","marketStatusCode":7,"change":0.01,"latestTime":"09-17 16:08:15","open":1.22,"high":1.22,"low":1.16,"amount":5430,"amplitude":0.051282,"askPrice":1.22,"askSize":15000,"bidPrice":1.18,"bidSize":62000,"shortable":0,"etf":0,"ttmEps":0.107091,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1726709400000},"adr":0,"adjPreClose":1.17,"dividendRate":0.025424,"openAndCloseTimeList":[[1726536600000,1726545600000],[1726549200000,1726560000000]],"volumeRatio":0.11860707856422738,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00950/tweets","defaultTab":"tweets","newsList":[{"id":"2467791139","title":"李氏大药厂(00950)股价下跌5.085%,现价港币$1.12","url":"https://stock-news.laohu8.com/highlight/detail?id=2467791139","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467791139?lang=zh_cn&edition=full","pubTime":"2024-09-13 13:03","pubTimestamp":1726203780,"startTime":"0","endTime":"0","summary":"[下跌股]李氏大药厂(00950) 股价在下午01:03比前收市价下跌5.085%,现股价为港币$1.12。至目前为止,今日最高价为$1.15,而最低价为$1.12。总成交量为3500股,总成交金额为港币$3950。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152745608_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152745608_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2409131423/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1587","06622","BK1583","BK1191","00950"],"gpt_icon":0},{"id":"2462666436","title":"李氏大药厂(00950)将于10月3日派发中期股息每股0.02港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2462666436","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462666436?lang=zh_cn&edition=full","pubTime":"2024-08-28 17:03","pubTimestamp":1724835826,"startTime":"0","endTime":"0","summary":"李氏大药厂(00950)发布公告,该公司将于2024年10月3日派发中期股息每股0...","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_14.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_14.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1173142.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1587","BK1583","BK1191","06622","BK1574","00950"],"gpt_icon":0},{"id":"2462343557","title":"李氏大药厂(00950.HK):上半年实现纯利6247.8万港元 同比增加287.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462343557","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462343557?lang=zh_cn&edition=full","pubTime":"2024-08-28 17:03","pubTimestamp":1724835781,"startTime":"0","endTime":"0","summary":"格隆汇8月28日丨李氏大药厂发布公告,截至2024年6月30日止六个月,实现收益6.58亿港元,同比增加28.5%;毛利为3.51亿港元,同比增加23.2%;公司拥有人应占溢利6247.8万港元,同比增加287.7%;基本每股盈利10.61港仙,每股中期股息2.00港仙。2024年上半年,集团的收益为较去年同期大增28.5%。此等销售增幅不仅带动收益录得可观增长,亦有助于抵销回顾期内若干产品销售额停滞不前的影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082817030995cbc788&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082817030995cbc788&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00950","BK1583","06622","BK1587","BK1574","BK1191"],"gpt_icon":0},{"id":"2462982983","title":"李氏大药厂盘中异动 早盘急速下挫5.69%报1.160港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2462982983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462982983?lang=zh_cn&edition=full","pubTime":"2024-08-26 10:03","pubTimestamp":1724637803,"startTime":"0","endTime":"0","summary":"2024年08月26日早盘10时03分,李氏大药厂股票出现波动,股价快速跳水5.69%。截至发稿,该股报1.160港元/股,成交量1.65万股,换手率0.00%,振幅8.13%。资金方面,该股资金流入630港元,流出1.916万港元。李氏大药厂股票所在的药品行业中,整体涨幅为0.14%。其相关个股中,励晶太平洋、君圣泰医药-B、联康生物科技集团涨幅较大,振幅较大的相关个股有艾美疫苗、君圣泰医药-B、李氏大药厂,振幅分别为12.21%、8.46%、8.13%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082610032397199ed2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082610032397199ed2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1587","BK1191","06622","BK1574","00950"],"gpt_icon":0},{"id":"2459608295","title":"李氏大药厂(00950.HK)拟8月28日举行董事会会议审批中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2459608295","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459608295?lang=zh_cn&edition=full","pubTime":"2024-08-16 17:24","pubTimestamp":1723800252,"startTime":"0","endTime":"0","summary":"格隆汇8月16日丨李氏大药厂(00950.HK)公告,公司董事会会议将于2024年8月28日(星期三)于香港新界沙田香港科学园第三期科技大道东20E大楼1楼举行,为审议(其中包括)并批准(如认为合适)刊发公司及其附属公司截至2024年6月30日止6个月的未经审核中期业绩公布及考虑建议中期股息(如有)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816172412a1d49f76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240816172412a1d49f76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1587","06622","BK1583","00950","BK1191"],"gpt_icon":0},{"id":"2457380460","title":"李氏大药厂盘中异动 早盘快速跳水7.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457380460","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457380460?lang=zh_cn&edition=full","pubTime":"2024-08-08 10:37","pubTimestamp":1723084672,"startTime":"0","endTime":"0","summary":"2024年08月08日早盘10时37分,李氏大药厂股票出现波动,股价快速下挫7.26%。截至发稿,该股报1.150港元/股,成交量1.9万股,换手率0.00%,振幅2.42%。李氏大药厂股票所在的药品行业中,整体跌幅为0.01%。李氏大药厂公司简介:李氏大药厂控股有限公司是一家主要从事药品开发、制造、市场推广及销售业务的香港投资控股公司。消息层面,截至10时37分,李氏大药厂股票正面舆情新闻比例45.45%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808103752ab5d8d5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240808103752ab5d8d5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","BK1587","BK1583","00950","06622"],"gpt_icon":0},{"id":"2457064365","title":"李氏大药厂盘中异动 下午盘快速拉升5.22%报1.210港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457064365","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457064365?lang=zh_cn&edition=full","pubTime":"2024-08-06 14:15","pubTimestamp":1722924908,"startTime":"0","endTime":"0","summary":"2024年08月06日下午盘14时15分,李氏大药厂股票出现波动,股价快速拉升5.22%。截至发稿,该股报1.210港元/股,成交量23.05万股,换手率0.04%,振幅4.35%。李氏大药厂股票所在的药品行业中,整体涨幅为0.50%。消息层面,截至14时15分,李氏大药厂股票正面舆情新闻比例62.5%。该信息摘要如下:李氏大药厂发布公告,该集团预期截至2024年6月30日止6个月将取得股东应占未经审核纯利介乎5800万港元至6300万港元,而截至2023年6月30日止6个月则取得约1600万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806141509aefd70c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806141509aefd70c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06622","BK1583","BK1574","BK1191","00950","BK1587"],"gpt_icon":0},{"id":"2457711264","title":"【港股异动 | 李氏大药厂(00950.HK)现涨超7% 预计上半年纯利最高达6300万港元】智通财经APP获悉,李氏大药厂(00950.","url":"https://stock-news.laohu8.com/highlight/detail?id=2457711264","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457711264?lang=zh_cn&edition=full","pubTime":"2024-08-05 15:14","pubTimestamp":1722842080,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["00950","BK1583","06622","BK1587","BK1574","BK1191"],"gpt_icon":0},{"id":"2457711214","title":"港股异动 | 李氏大药厂(00950)现涨超7% 预计上半年纯利最高达6300万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457711214","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457711214?lang=zh_cn&edition=full","pubTime":"2024-08-05 15:14","pubTimestamp":1722842080,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,李氏大药厂(00950)现涨超7%,早盘曾高开近15%。截至发稿,涨7.41%,报1.16港元,成交额40.75万港元。消息面上,李氏大药厂发盈喜,预期截至2024年6月30日止6个月将取得股东应占未经审核纯利介乎5800万港元至6300万港元,去年同期则取得约1600万港元。主要受益于获纳入最新版《国家基本医疗保险、工伤保险和生育保险药品目录》之产品连同药品集采计划之选定产品销售增长,期内显著改善销售收益;研究及开发费用减少约1470万港元;及优化管理所节省之成本。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1159901.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","06622","BK1583","BK1191","00950","BK1587"],"gpt_icon":0},{"id":"2457797988","title":"【盈喜股】李氏大药厂(00950)逆市涨8.33% 料中期股东应占纯利至多6300万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457797988","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457797988?lang=zh_cn&edition=full","pubTime":"2024-08-05 13:34","pubTimestamp":1722836079,"startTime":"0","endTime":"0","summary":"金吾财讯 | 李氏大药厂 盘中曾涨超13%,截至发稿,涨8.33%,报1.17港元。消息面上公司公布,集团预期截至2024年6月30日止六个月将录得股东应占未经审核纯利介乎5800万亿港元至6300万港元,而截至2023年6月30日止六个月则录得约1600万港元。","market":"fut","thumbnail":"https://static.szfiu.com/news/20200915/NWNhYTJjYTdkNzllNGFmZDMzMTYwMDE1MDIxMjI0Mw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200915/NWNhYTJjYTdkNzllNGFmZDMzMTYwMDE1MDIxMjI0Mw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1941656","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622","BK1587","BK1191","BK1583","BK1574","00950"],"gpt_icon":0},{"id":"2457764896","title":"李氏大药厂股价飙升11.01% 市值涨7850.33万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457764896","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457764896?lang=zh_cn&edition=full","pubTime":"2024-08-05 09:37","pubTimestamp":1722821843,"startTime":"0","endTime":"0","summary":"2024年08月05日早盘09时37分,李氏大药厂股票出现波动,股价急速拉升11.01%。李氏大药厂股票所在的药品行业中,整体跌幅为0.11%。消息层面,截至09时37分,李氏大药厂股票正面舆情新闻比例100%。该信息摘要如下:李氏大药厂发布公告,该集团预期截至2024年6月30日止6个月将取得股东应占未经审核纯利介乎5800万港元至6300万港元,而截至2023年6月30日止6个月则取得约1600万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805093723941fdbdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805093723941fdbdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06622","BK1583","BK1587","BK1191","00950"],"gpt_icon":0},{"id":"2457691727","title":"港股异动丨发盈喜,李氏大药厂逆势高开近15%李氏大药厂(0950.HK)今早逆势高开14.81%报1.24港元,创6月14日以来新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2457691727","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457691727?lang=zh_cn&edition=full","pubTime":"2024-08-05 09:24","pubTimestamp":1722821056,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["06622","BK1587","00950","BK1574","BK1583","BK1191"],"gpt_icon":0},{"id":"2457766781","title":"【公司盈喜】李氏大药厂(00950)料中期股东应占纯利增长至最多6300万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457766781","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457766781?lang=zh_cn&edition=full","pubTime":"2024-08-05 08:55","pubTimestamp":1722819336,"startTime":"0","endTime":"0","summary":"金吾财讯 | 李氏大药厂(00950)公布,集团预期截至2024年6月30日止六个月将录得股东应占未经审核纯利介乎5800万亿港元至6300万港元,而截至2023年6月30日止六个月则录得约1600万港元。中期业绩有所改善主要因为:(i)获纳入最新版《国家基本医疗保险、工伤保险和生育保险药品目录》之产品(例如曲前列尼尔注射液《芮旎尔》、《芮舒延》及《曲特恪》)连同药品集采计划之选定产品(例如那曲肝素钙注射液《立腾菁》)之销售增长于回顾期内显着改善销售收益;(ii)藉优化研究及开发组合使研究及开发费用减少约14,700,000港元;及(iii)集团优化管理之举措所节省之成本。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/OWRlOWUwM2UzYzc0YWVmOThhNzQ1ZDFlMmFkZGIzYjY4MTQyOTUwNzU2MTA=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/OWRlOWUwM2UzYzc0YWVmOThhNzQ1ZDFlMmFkZGIzYjY4MTQyOTUwNzU2MTA=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1941615","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06622","BK1583","BK1574","BK1191","00950","BK1587"],"gpt_icon":0},{"id":"2457718757","title":"李氏大药厂发盈喜 预计中期股东应占纯利5800万至6300万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457718757","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457718757?lang=zh_cn&edition=full","pubTime":"2024-08-05 06:45","pubTimestamp":1722811538,"startTime":"0","endTime":"0","summary":"李氏大药厂(00950)发布公告,该集团预期截至2024年6月30日止6个月将取得股东应占未经审核纯利介乎5800万港元至6300万港元,而截至2023年6月30日止6个月则取得约1600万港元。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-08-05/doc-inchpwer8051867.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-08-05/doc-inchpwer8051867.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1587","BK1191","06622","BK1574","BK1583","00950"],"gpt_icon":0},{"id":"2456731501","title":"李氏大药厂发盈喜:料中期盈利升至5800万-6300万李氏大药厂(0950.HK)发盈喜,预期截至6月底止上半年将录得股东应占纯利介乎5800万至6300万港元,而2023年同期则录得约1600万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456731501","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456731501?lang=zh_cn&edition=full","pubTime":"2024-08-04 20:32","pubTimestamp":1722774723,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["00950","BK1583","06622","BK1587","BK1574","BK1191"],"gpt_icon":0},{"id":"2456173640","title":"《盈喜》李氏大药厂(00950.HK)半年纯利倍翻 最少赚5,800万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456173640","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456173640?lang=zh_cn&edition=full","pubTime":"2024-08-04 19:26","pubTimestamp":1722770760,"startTime":"0","endTime":"0","summary":"李氏大药厂发盈喜,预计6月止六个月纯利介乎5,800万至6,300万元,相较上年同期录得1,600万元。主要源于获纳入最新版《国家基本医疗保险、工伤保险和生育保险药品目录》之产品连同药品集采计划之选定产品销售增长,期内显著改善销售收益;研究及开发费用减少约1,470万元;及优化管理所节省之成本。)过往派息公布日期派息事项派息内容2024/03/26末期业绩普通股息:港元 0.012023/08/30中期业绩普通股息:港元 0.0082023/03/30末期业绩普通股息:港元 0.01002022/11/17第三季业绩无派息 AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200406164120357_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200406164120357_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1368689/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","00950","BK1191","BK1587","06622","BK1574"],"gpt_icon":0},{"id":"2456736587","title":"【李氏大药厂(00950.HK)发盈喜,预计中期股东应占纯利5800万港元至6300万港元 同比增长】智通财经APP讯,李氏大药厂(00950.","url":"https://stock-news.laohu8.com/highlight/detail?id=2456736587","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456736587?lang=zh_cn&edition=full","pubTime":"2024-08-04 19:09","pubTimestamp":1722769797,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1587","BK1583","BK1191","06622","BK1574","00950"],"gpt_icon":0},{"id":"2456736322","title":"李氏大药厂(00950)发盈喜,预计中期股东应占纯利5800万港元至6300万港元 同比增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2456736322","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456736322?lang=zh_cn&edition=full","pubTime":"2024-08-04 19:09","pubTimestamp":1722769797,"startTime":"0","endTime":"0","summary":"智通财经APP讯,李氏大药厂 发布公告,该集团预期截至2024年6月30日止6个月将取得股东应占未经审核纯利介乎5800万港元至6300万港元,而截至2023年6月30日止6个月则取得约1600万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1159707.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1587","06622","BK1191","00950","BK1583","BK1574"],"gpt_icon":0},{"id":"2456136234","title":"李氏大药厂(00950.HK):香港首名患者已入组接受AU409治疗临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2456136234","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456136234?lang=zh_cn&edition=full","pubTime":"2024-08-02 08:52","pubTimestamp":1722559920,"startTime":"0","endTime":"0","summary":"李氏大药厂公布,香港玛丽医院首名患者于7月15日已入组接受AU409治疗之第I期临床试验。主要目标为确定最大耐受剂量及第II期建议剂量,并描述AU409之安全性及耐受性。次要目标包括评估AU409之药代动力学及初步抗肿瘤活性。临床前研究显示,AU409可变换若干基因之转录,从而改变肝癌细胞之基因表达谱。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200406164356449_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200406164356449_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1368333/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","06622","BK1574","BK1141","00950","BK1583","03347","BK1576","BK1587"],"gpt_icon":0},{"id":"2456141327","title":"李氏大药厂:AU409临床研究预计25年中结束","url":"https://stock-news.laohu8.com/highlight/detail?id=2456141327","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456141327?lang=zh_cn&edition=full","pubTime":"2024-08-02 08:03","pubTimestamp":1722557025,"startTime":"0","endTime":"0","summary":"【李氏大药厂公告:2024 年 7 月 15 日香港玛丽医院首名患者入组接受 AU409 治疗第 I 期临床试验】AU409 是由 Auransa Inc.发现及拥有的新药,由集团全资附属公司兆科药业有限公司制造,符合美国食品药品监督管理局订立的药品生产质量管理规范。此次试验主要针对曾接受标准一线治疗但无效的晚期肝细胞癌患者,是亚洲首项人体试验研究,预计 2025 年第二季度结束,研究结果将用于中国的新药注册。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408020901109f06ec02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408020901109f06ec02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00950","BK1583","06622","BK1587","BK1574","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.leespharm.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0172},{"period":"3month","weight":0},{"period":"6month","weight":-0.0552},{"period":"1year","weight":-0.0767},{"period":"ytd","weight":-0.2154}],"compareEarnings":[{"period":"1week","weight":0.0247},{"period":"1month","weight":0.0132},{"period":"3month","weight":-0.0418},{"period":"6month","weight":0.0473},{"period":"1year","weight":-0.0151},{"period":"ytd","weight":0.0359}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"李氏大药厂控股有限公司是一家主要从事药品开发、制造、市场推广及销售业务的香港投资控股公司。该公司通过两大分部运营。专利产品分部制造及销售自行研发的产品。其研发产品包括“尤靖安”、“立迈青”及“速乐涓”等。引进产品分部买卖引进的产品。其引进产品包括“菲普利”及“再宁平”等。该公司药品覆盖心血管及传染疾病、皮肤医学、肿瘤学、妇科学及眼科学等领域。该公司主要在中国及香港开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.062131},{"month":2,"riseRate":0.357143,"avgChangeRate":-0.020416},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.032002},{"month":4,"riseRate":0.5,"avgChangeRate":0.009706},{"month":5,"riseRate":0.642857,"avgChangeRate":0.034989},{"month":6,"riseRate":0.4,"avgChangeRate":-0.025649},{"month":7,"riseRate":0.466667,"avgChangeRate":0.002065},{"month":8,"riseRate":0.4,"avgChangeRate":-0.034406},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.002255},{"month":10,"riseRate":0.5,"avgChangeRate":0.004945},{"month":11,"riseRate":0.642857,"avgChangeRate":0.022972},{"month":12,"riseRate":0.428571,"avgChangeRate":0.013014}],"exchange":"SEHK","name":"李氏大药厂","nameEN":"LEE'S PHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"李氏大药厂(00950)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供李氏大药厂(00950)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"李氏大药厂,00950,李氏大药厂股票,李氏大药厂股票老虎,李氏大药厂股票老虎国际,李氏大药厂行情,李氏大药厂股票行情,李氏大药厂股价,李氏大药厂股市,李氏大药厂股票价格,李氏大药厂股票交易,李氏大药厂股票购买,李氏大药厂股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"李氏大药厂(00950)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供李氏大药厂(00950)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}